+44 (0) 20 3997 7634 | sales@fbkmed.com

Can CT measures of tumour heterogeneity stratify risk for nodal metastasis in patients with non-small cell lung cancer?

Home > Can CT measures of tumour heterogeneity stratify risk for nodal metastasis in patients with non-small cell lung cancer?

Can CT measures of tumour heterogeneity stratify risk for nodal metastasis in patients with non-small cell lung cancer?

13/10/17

Latest Articles

Appointment of in-country managing director

12/09/23

Bleepa Feedback Medical Feedback PLC

Annual results: Laying the foundations for growth

12/09/23

Bleepa Feedback Medical Feedback PLC

Year end trading update

19/06/23

Bleepa Cadran Feedback Medical Feedback PLC